S.2577 - A bill to amend the Internal Revenue Code of 1986 to extend the credit for clinical testing expenses for certain drugs for rare diseases or conditions, and for other purposes.101st Congress (1989-1990)
|Sponsor:||Sen. Metzenbaum, Howard M. [D-OH] (Introduced 05/03/1990)|
|Committees:||Senate - Finance|
|Latest Action:||Senate - 05/03/1990 Read twice and referred to the Committee on Finance. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
Summary: S.2577 — 101st Congress (1989-1990)All Information (Except Text)
Introduced in Senate (05/03/1990)
Amends the Internal Revenue Code to extend through 1993 the tax credit for clinical testing expenses for certain drugs for rare diseases or conditions. Includes preclinical testing expenses under such tax credit.
Provides for determining the credit recapture amount when using preclinical testing of a drug for a disease or condition that has not previously been designated as a rare disease or condition.